Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1503518/000110465916096509/a15-18065_110q.htm
Exhibit 99.1
21ST CENTURY ONCOLOGY HOLDINGS, INC. | |||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||||
(in thousands, except share amounts) | |||||||||||||
(unaudited) | |||||||||||||
|
|
|
PRELIMINARY |
|
ADJUSTMENTS |
|
|
|
FINAL |
| |||
|
|
|
September 30, |
|
September 30, |
|
|
|
September 30, |
| |||
|
|
|
2015 |
|
2015 |
|
|
|
2015 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
ASSETS | |||||||||||||
|
Current assets: |
|
|
|
|
|
|
|
|
| |||
|
Cash and cash equivalents |
|
$ |
47,793 |
|
$ |
|
|
|
|
$ |
47,793 |
|
|
Restricted cash |
|
80 |
|
|
|
|
|
80 |
| |||
|
Marketable securities |
|
622 |
|
|
|
|
|
622 |
| |||
|
Accounts receivable, net |
|
149,224 |
|
|
|
|
|
149,224 |
| |||
|
Prepaid expenses |
|
9,381 |
|
|
|
|
|
9,381 |
| |||
|
Inventories |
|
5,162 |
|
|
|
|
|
5,162 |
| |||
|
Deferred income taxes |
|
191 |
|
|
|
|
|
191 |
| |||
|
Other |
|
8,056 |
|
|
|
|
|
8,056 |
| |||
|
Total current assets |
|
220,509 |
|
|
|
|
|
220,509 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Equity investments in joint ventures |
|
1,236 |
|
|
|
|
|
1,236 |
| |||
|
Property and equipment, net |
|
249,392 |
|
|
|
|
|
249,392 |
| |||
|
Real estate subject to finance obligation |
|
11,625 |
|
|
|
|
|
11,625 |
| |||
|
Goodwill |
|
492,084 |
|
|
|
|
|
492,084 |
| |||
|
Intangible assets, net |
|
74,434 |
|
|
|
|
|
74,434 |
| |||
|
Other assets |
|
49,282 |
|
|
|
|
|
49,282 |
| |||
|
Total assets |
|
$ |
1,098,562 |
|
$ |
|
|
|
|
$ |
1,098,562 |
|
|
|
|
|
|
|
|
|
|
|
| |||
LIABILITIES AND EQUITY | |||||||||||||
|
|
|
|
|
|
|
|
|
|
| |||
|
Current liabilities: |
|
|
|
|
|
|
|
|
| |||
|
Accounts payable |
|
$ |
59,397 |
|
$ |
|
|
|
|
$ |
59,397 |
|
|
Accrued expenses |
|
111,084 |
|
28,977 |
|
A |
|
140,061 |
| |||
|
Income taxes payable |
|
1,814 |
|
|
|
|
|
1,814 |
| |||
|
Current portion of long-term debt |
|
30,858 |
|
|
|
|
|
30,858 |
| |||
|
Current portion of finance obligation |
|
481 |
|
|
|
|
|
481 |
| |||
|
Other current liabilities |
|
6,484 |
|
|
|
|
|
6,484 |
| |||
|
Total current liabilities |
|
210,118 |
|
28,977 |
|
|
|
239,095 |
| |||
|
Long-term debt, less current portion |
|
1,009,196 |
|
|
|
|
|
1,009,196 |
| |||
|
Finance obligation, less current portion |
|
12,057 |
|
|
|
|
|
12,057 |
| |||
|
Embedded derivative & other financial instrument features of Series A convertible redeemable preferred stock |
|
23,541 |
|
3,798 |
|
B |
|
27,339 |
| |||
|
Other long-term liabilities |
|
39,861 |
|
|
|
|
|
39,861 |
| |||
|
Deferred income taxes |
|
3,716 |
|
|
|
|
|
3,716 |
| |||
|
Total liabilities |
|
1,298,489 |
|
32,775 |
|
|
|
1,331,264 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014 |
|
404,179 |
|
(33,701 |
) |
C |
|
370,478 |
| |||
|
Noncontrolling interests - redeemable |
|
19,934 |
|
|
|
|
|
19,934 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Equity: |
|
|
|
|
|
|
|
|
| |||
|
Common stock, $0.01 par value, 1,000,000 shares authorized 1,059 and 1,028 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively |
|
|
|
|
|
|
|
|
| |||
|
Additional paid-in capital |
|
569,036 |
|
30,697 |
|
D |
|
599,733 |
| |||
|
Retained deficit |
|
(1,174,400 |
) |
(29,771 |
) |
E |
|
(1,204,171 |
) | |||
|
Accumulated other comprehensive loss, net of tax |
|
(45,008 |
) |
|
|
|
|
(45,008 |
) | |||
|
Total 21st Century Oncology Holdings, Inc. shareholders deficit |
|
(650,372 |
) |
926 |
|
|
|
(649,446 |
) | |||
|
Noncontrolling interests - nonredeemable |
|
26,332 |
|
|
|
|
|
26,332 |
| |||
|
Total deficit |
|
(624,040 |
) |
926 |
|
|
|
(623,114 |
) | |||
|
Total liabilities and equity |
|
$ |
1,098,562 |
|
$ |
|
|
|
|
$ |
1,098,562 |
|
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by 21St Century Oncology Holdings, Inc..
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1503518/000110465916096509/a15-18065_110q.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years